Citigroup
AIM icon

Citigroup’s AIM ImmunoTech AIM Stock Holding History

Citigroup’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.49K Buy
+37,079
New +$9.06K ﹤0.01% 5304
2025
Q1 		– Sell
-9
Closed -$171 – 6124
2024
Q4 		$171 Buy
+9
New +$210 ﹤0.01% 5669
2021
Q2 		– Sell
-1
Closed – – 6654
2021
Q1 		$0 Hold
1
– – ﹤0.01% 7934
2020
Q4 		$0 Hold
1
– – ﹤0.01% 7861
2020
Q3 		$0 Hold
1
– – ﹤0.01% 7807
2020
Q2 		$0 Hold
1
– – ﹤0.01% 7908
2020
Q1 		$0 Buy
+1
New +$157 ﹤0.01% 8003
2016
Q2 		– Hold
0
– – – 8007
2016
Q1 		– Hold
0
– – – 8300
2014
Q2 		– Sell
-1
Closed -$14K – 7725
2014
Q1 		$14K Buy
+1
New +$21.2K ﹤0.01% 6224
2013
Q4 		– Hold
0
– – – 7525
2013
Q3 		– Hold
0
– – – 7369
2013
Q2 		– Hold
0
– – – 6721

Other funds holding AIM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Community Bank
Community Bank Dewitt, New York $933M AUM 24.36% 1-Year Est. Return
Creative Financial Designs
Creative Financial Designs Kokomo, Indiana $2.22B AUM 15.38% 1-Year Est. Return
Hoey Investments
Hoey Investments Coatesville, Pennsylvania $851M AUM 28.55% 1-Year Est. Return
Cassaday & Co Wealth Management
Cassaday & Co Wealth Management Mclean, Virginia $5.65B AUM 14.23% 1-Year Est. Return

Citigroup's AIM Position: Q3 2026 in Review

Citigroup opened a new position in AIM ImmunoTech (AIM) in Q3 2026: 37,079 shares worth $6.49K. The stake represents ﹤0.01% of the portfolio and ranks #5304 among its holdings. This is a return to the name: Citigroup previously reported a position in AIM as recently as Q4 2024.

Citigroup first reported a position in AIM in Q1 2014 and has held it in 8 quarters since. The position peaked at $14K in Q1 2014. 8 funds tracked by Wall St. Rank hold AIM as of Q3 2026.

  • Citigroup held 37,079 shares of AIM ImmunoTech worth $6.49K as of Q3 2026.
  • AIM ImmunoTech was a new Citigroup position in Q3 2026.
  • AIM ImmunoTech made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5304 holding.
  • Citigroup first reported a position in AIM ImmunoTech in Q1 2014 and has held it in 8 quarters since.
  • Citigroup's AIM ImmunoTech position peaked at $14K in Q1 2014.
  • 8 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.